| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |